![](/images/graphics-bg.png)
Targeting the EGF Receptor for Ovarian Cancer Therapy
Joint Authors
Stack, M. Sharon
Hudson, Laurie G.
Muller, Carolyn Y.
Zeineldin, Reema
Source
Issue
Vol. 2010, Issue 2010 (31 Dec. 2010), pp.1-11, 11 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2009-12-28
Country of Publication
Egypt
No. of Pages
11
Main Subjects
Abstract EN
Ovarian carcinoma is the leading cause of death from gynecologic malignancy in the US.
Factors such as the molecular heterogeneity of ovarian tumors and frequent diagnosis at advanced stages hamper effective disease treatment.
There is growing emphasis on the identification and development of targeted therapies to disrupt molecular pathways in cancer.
The epidermal growth factor (EGF) receptor is one such protein target with potential utility in the management of ovarian cancer.
This paper will discuss contributions of EGF receptor activation to ovarian cancer pathogenesis and the status of EGF receptor inhibitors and EGF receptor targeted therapies in ovarian cancer treatment.
American Psychological Association (APA)
Zeineldin, Reema& Muller, Carolyn Y.& Stack, M. Sharon& Hudson, Laurie G.. 2009. Targeting the EGF Receptor for Ovarian Cancer Therapy. Journal of Oncology،Vol. 2010, no. 2010, pp.1-11.
https://search.emarefa.net/detail/BIM-470273
Modern Language Association (MLA)
Zeineldin, Reema…[et al.]. Targeting the EGF Receptor for Ovarian Cancer Therapy. Journal of Oncology No. 2010 (2010), pp.1-11.
https://search.emarefa.net/detail/BIM-470273
American Medical Association (AMA)
Zeineldin, Reema& Muller, Carolyn Y.& Stack, M. Sharon& Hudson, Laurie G.. Targeting the EGF Receptor for Ovarian Cancer Therapy. Journal of Oncology. 2009. Vol. 2010, no. 2010, pp.1-11.
https://search.emarefa.net/detail/BIM-470273
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-470273